{"title":"“基于不同冠状病毒刺突蛋白和ACE2分子对接研究开发SARS-CoV-2抑制剂”的勘误[J] . Mol对接，2021;1(2):1-14]","authors":"Israa. M. Shamkh, D. Pratiwi, Hanaa S. Omar","doi":"10.33084/jmd.v1i2.3063","DOIUrl":null,"url":null,"abstract":"Authors have found an error in the previous version (Shamkh, IM, & Pratiwi, D. (2021). Development of SARS-CoV-2 Inhibitors Using Molecular Docking Study with Different Coronavirus Spike Protein and ACE2. Journal of Molecular Docking, 1(1), 1-14. https://doi.org/10.33084/jmd.v1i1.2212), of which Dr. Hanaa S. Omar as supervisor of the research, is not listed as one of the authors. In this note, Dr. Hanaa S. Omar was added as one of the authors, with the status of the corresponding author in the study.","PeriodicalId":16421,"journal":{"name":"Journal of Molecular Docking","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Corrigendum to \\\"Development of SARS-CoV-2 Inhibitors Using Molecular Docking Study with Different Coronavirus Spike Protein and ACE2” [J Mol Docking. 2021;1(2):1-14]\",\"authors\":\"Israa. M. Shamkh, D. Pratiwi, Hanaa S. Omar\",\"doi\":\"10.33084/jmd.v1i2.3063\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Authors have found an error in the previous version (Shamkh, IM, & Pratiwi, D. (2021). Development of SARS-CoV-2 Inhibitors Using Molecular Docking Study with Different Coronavirus Spike Protein and ACE2. Journal of Molecular Docking, 1(1), 1-14. https://doi.org/10.33084/jmd.v1i1.2212), of which Dr. Hanaa S. Omar as supervisor of the research, is not listed as one of the authors. In this note, Dr. Hanaa S. Omar was added as one of the authors, with the status of the corresponding author in the study.\",\"PeriodicalId\":16421,\"journal\":{\"name\":\"Journal of Molecular Docking\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-12-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Molecular Docking\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33084/jmd.v1i2.3063\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Molecular Docking","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33084/jmd.v1i2.3063","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
摘要
作者在之前的版本中发现了一个错误(Shamkh, IM， & Pratiwi, D.(2021))。利用不同冠状病毒刺突蛋白和ACE2分子对接研究开发SARS-CoV-2抑制剂分子对接学报，1(1)，1-14。https://doi.org/10.33084/jmd.v1i1.2212)， Hanaa S. Omar博士是该研究的主管，但并未被列为作者之一。本注中增加了Hanaa S. Omar博士为作者之一，并注明了本研究通讯作者的身份。
Corrigendum to "Development of SARS-CoV-2 Inhibitors Using Molecular Docking Study with Different Coronavirus Spike Protein and ACE2” [J Mol Docking. 2021;1(2):1-14]
Authors have found an error in the previous version (Shamkh, IM, & Pratiwi, D. (2021). Development of SARS-CoV-2 Inhibitors Using Molecular Docking Study with Different Coronavirus Spike Protein and ACE2. Journal of Molecular Docking, 1(1), 1-14. https://doi.org/10.33084/jmd.v1i1.2212), of which Dr. Hanaa S. Omar as supervisor of the research, is not listed as one of the authors. In this note, Dr. Hanaa S. Omar was added as one of the authors, with the status of the corresponding author in the study.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
